Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117005) titled 'A study to evaluate the effectiveness and Safety of Ostizeel Tablet in patients aged 40 to 65 Years with Knee Osteoarthritis' on Sept. 3.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded
Primary Sponsor: MAKIN LABORATORIES PRIVATE LIMITED
Condition:
Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Interventi...